CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Conversion 10% owner acquired 1,114,043 shares (conversion)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,000 shares at $1.65 ($4,950)
- 4 Open-market buy Director bought 5,000 shares at $1.92 ($9,600)
- 4 Conversion Director acquired 996,779 shares (conversion)
- 4 Conversion 10% owner acquired 996,779 shares (conversion)
- 4 Conversion Director acquired 142,396 shares (conversion)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.95 ($9,731)
- 4 Open-market buy President and CEO bought 5,000 shares at $2.01 ($10,040)
- 8-K Event Shareholder vote results
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
Page 38 of 45 · 895 filings